Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2014

View Archived Issues

Eli Lilly and Immunocore to discover and develop novel cancer therapies

TTP-054 demonstrates the ability to lower HbA1c in patients with type 2 diabetes

Chase Pharmaceuticals to begin phase II study of CPC-201

Researchers present novel ASOs as potential therapies for tauopathies

Virobay completes series B financing round

Enrollment completed in study of protein-based biomarker blood test for breast cancer

Novel agents for tuberculosis patented by Janssen R&D Ireland

Galapagos designs new GPR84 agonists

Cellerant Therapeutics divulges new anti-IL1RAP MAbs

AVEO Pharmaceuticals presents new anti-GDF-15 MAbs

Researchers at Rockefeller University patent new modified anti-CD4 MAbs

Significant benefits seen with DA-1229 in diabetes trial

New anti-Notch 3 antibodies selected by AVEO Pharmaceuticals

French group patents new spiroisoxazoline derivatives

Phase III trial of biosimilar of etanercept begins in chronic plaque psoriasis

Capricor Therapeutics reports results from phase I portion of the ALLSTAR trial

Isis Pharmaceuticals begins phase II study of ISIS-APO(a)Rx in patients with high Lp(a)

ImQuest Pharmaceuticals receives FDA approval to initiate trials of IQP-0528 gel

Resolve Therapeutics begins phase II study of RSLV-132 in SLE

OncoMed Pharmaceuticals begins phase II ALPINE trial of tarextumab

Phase III study of trametinib and dabrafenib in melanoma stopped early due to benefit

FDA grants breakthrough therapy designation to pirfenidone for IPF

Cynapsus begins phase II studies of APL-130277 in Parkinson's disease

Ruthigen treats first subjects in trial of RUT-58-60

Seres Health completes enrollment in study of SER-109

Researchers develop low-cost, rapid, point-of-care test for the detection of M. tuberculosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.